[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.

IF 4.9 3区 医学 Q1 ONCOLOGY
International journal of oncology Pub Date : 2025-10-01 Epub Date: 2025-08-24 DOI:10.3892/ijo.2025.5790
Koh-Ichi Nakashiro, Hiroshi Tanaka, Hiroyuki Goda, Kazuki Iwamoto, Norihiko Tokuzen, Shingo Hara, Jun Onodera, Satoshi Hino, Hiroyuki Hamakawa
{"title":"[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.","authors":"Koh-Ichi Nakashiro, Hiroshi Tanaka, Hiroyuki Goda, Kazuki Iwamoto, Norihiko Tokuzen, Shingo Hara, Jun Onodera, Satoshi Hino, Hiroyuki Hamakawa","doi":"10.3892/ijo.2025.5790","DOIUrl":null,"url":null,"abstract":"<p><p>Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, regarding the western blots shown in Figs. 1C and 3A, the six lanes for the control β‑tubulin blots shown in Fig. 1C appeared strikingly similar to the β‑tubulin blots in Fig. 3A, albeit the bands in Fig. 3A appeared to have been horizontally stretched. The authors were able to check their original data, and realized that Fig. 3 had inadvertently been assembled incorrectly. A revised version of Fig. 3, now showing data for both the Akt1 and β‑tubulin blots from one of the repeated experiments, is shown opposite. All authors confirm that the errors made in assembling Fig. 3 did not have a major impact on the conclusions reported in the above article, and they thank the Editor of <i>International Journal of Oncology</i> for allowing them the opportunity to publish a Corrigendum. Furthermore, all the authors agree to the publication of this Corrigendum, and apologize to the readers for any inconvenience caused. [International Journal of Oncology 47: 1273‑1281, 2015; DOI: 10.3892/ijo.2015.3134].</p>","PeriodicalId":14175,"journal":{"name":"International journal of oncology","volume":"67 4","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12370364/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ijo.2025.5790","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, regarding the western blots shown in Figs. 1C and 3A, the six lanes for the control β‑tubulin blots shown in Fig. 1C appeared strikingly similar to the β‑tubulin blots in Fig. 3A, albeit the bands in Fig. 3A appeared to have been horizontally stretched. The authors were able to check their original data, and realized that Fig. 3 had inadvertently been assembled incorrectly. A revised version of Fig. 3, now showing data for both the Akt1 and β‑tubulin blots from one of the repeated experiments, is shown opposite. All authors confirm that the errors made in assembling Fig. 3 did not have a major impact on the conclusions reported in the above article, and they thank the Editor of International Journal of Oncology for allowing them the opportunity to publish a Corrigendum. Furthermore, all the authors agree to the publication of this Corrigendum, and apologize to the readers for any inconvenience caused. [International Journal of Oncology 47: 1273‑1281, 2015; DOI: 10.3892/ijo.2015.3134].

Abstract Image

[勘误]Akt1作为口腔鳞状细胞癌有效治疗靶点的鉴定。
在上述论文发表后,一位关心的读者引起了编辑的注意,关于图1C和3A所示的western blots,图1C所示的对照β微管蛋白blots的六个通道与图3A所示的β微管蛋白blots惊人地相似,尽管图3A中的条带似乎是水平拉伸的。作者能够检查他们的原始数据,并意识到图3是无意中组装错误的。图3的修订版,现在显示了来自重复实验之一的Akt1和β微管蛋白印迹的数据,显示的是相反的。所有作者都确认图3中的错误对上述文章的结论没有重大影响,并感谢《国际肿瘤学杂志》的编辑给他们发表勘误表的机会。此外,所有作者同意发表此勘误表,并对由此给读者带来的不便表示歉意。国际肿瘤学杂志47:1273‑1281,2015;DOI: 10.3892 / ijo.2015.3134]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.60
自引率
0.00%
发文量
157
审稿时长
2.1 months
期刊介绍: The main aim of Spandidos Publications is to facilitate scientific communication in a clear, concise and objective manner, while striving to provide prompt publication of original works of high quality. The journals largely concentrate on molecular and experimental medicine, oncology, clinical and experimental cancer treatment and biomedical research. All journals published by Spandidos Publications Ltd. maintain the highest standards of quality, and the members of their Editorial Boards are world-renowned scientists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信